Pharma channel feed

As­traZeneca moves for­ward with a $360M API plant in Ire­land

3 years ago
Manufacturing

Mer­ck-No­var­tis re­volv­ing door spins again as AI leader Iya Khalil switch­es phar­mas

3 years ago
People
AI

Af­ter a bad quar­ter, Il­lu­mi­na fo­cus­es on new DNA se­quenc­ing plat­form

3 years ago

How Pur­due's $272M ad­dic­tion pay­out fund­ed a new home for its dis­card­ed non-opi­oid re­search

3 years ago
In Focus

Re­searchers pan phar­ma DTC ad­ver­tis­ing for high spend­ing on low-val­ue drugs — JA­MA re­port

3 years ago
Marketing

Pfiz­er or­dered to dis­close FBI com­mu­ni­ca­tions in trade se­crets case

3 years ago
Law

Pa­tients, ad­vo­ca­cy groups launch fight against Trikaf­ta patents in four coun­tries

3 years ago

Chat­G­PT and gen­er­a­tive AI land in phar­ma mar­ket­ing with sense of awe — and plen­ty of cau­tion

3 years ago
Marketing

Mar­ket­ingRx roundup: Pfiz­er plans mar­ket­ing spend bump for 2023; Am­gen, Mer­ck join ‘Project Black’ eq­ui­ty fund­ing

3 years ago
Marketing

DC ap­peals court re­vives case ac­cus­ing phar­mas of fi­nanc­ing ter­ror at­tacks

3 years ago
Law

Bris­tol My­ers de­buts first pso­ri­a­sis drug ad on Gram­mys, lead­ing cho­rus of phar­ma brands

3 years ago
Marketing

Sanofi re­sponds to patent spat with Am­gen as Supreme Court ar­gu­ments set for March

3 years ago
Law

'S­mooth and very much on track': Ei­sai re­ports first ship­ments of Leqem­bi

3 years ago

Take­da snags ex­pand­ed pe­di­atric ap­proval for rare ge­net­ic dis­or­der drug

3 years ago

J&J clears PhII for rare blood dis­or­der with drug from $6.5B Mo­men­ta buy­out

3 years ago
R&D

Clin­i­cal tri­al di­ver­si­ty da­ta show mis­match be­tween en­roll­ment and dis­ease preva­lence, GSK says

3 years ago

Te­va drops out of in­dus­try trade group PhRMA

3 years ago

Sanofi sees downtick in flu sales as it preps for launch of RSV an­ti­body

3 years ago

Take­da fo­cus­es on ‘di­verse’ pipeline prospects on heels of two ac­qui­si­tions

3 years ago

In show­down with Roche, Re­gen­eron gears up for po­ten­tial Eylea ex­pan­sion amid Covid de­cline

3 years ago

In­fla­tion re­bates in­com­ing: Wyden calls on CMS to move quick­ly as No­var­tis CEO pledges re­ver­sal

3 years ago
Law

BeiGene re­veals men­tal health and can­cer care gap in study, de­buts dig­i­tal re­sources

3 years ago
Marketing

Gilead com­bines ar­ti­fi­cial in­tel­li­gence and art to draw at­ten­tion and hope to MBC

3 years ago
Marketing

Sanofi scraps PhI­II tri­al for Prin­cip­ia drug af­ter re­view­ing com­pe­ti­tion

3 years ago
R&D
First page Previous page 145146147148149150151 Next page Last page
A service from the Financial Times